LuciLorla is used in advanced ALK-positive lung cancer, especially after other treatments fail.
Active Ingredient
Lorlatinib is a third-generation ALK inhibitor.
Uses of LuciLorla
• ALK-positive NSCLC
How LuciLorla Works
Blocks ALK mutations and resistance pathways.
How to Use LuciLorla
• Take once daily
Possible Side Effects
• Weight gain
• Mood changes
Precautions
• Monitor cholesterol
Safety Information
Use under supervision.
Storage
• Store at room temperature
• Keep away from moisture
• Keep out of reach of children
